1-20 of 88564
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Tinne Gils and others
The Journal of Infectious Diseases, jiae374, https://doi.org/10.1093/infdis/jiae374
Published: 24 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Alyssa Lantz and others
The Journal of Infectious Diseases, jiae372, https://doi.org/10.1093/infdis/jiae372
Published: 24 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Jenna Alessandrini and others
The Journal of Infectious Diseases, jiae345, https://doi.org/10.1093/infdis/jiae345
Published: 23 July 2024
Image
Published: 23 July 2024
Figure 2. Detected drug resistance in Rhode Island, 2004–2021. A , Proportions of persons with drug resistance per the colored legend (any, nucleoside reverse transcriptase inhibitor [NRTI], nonnucleoside reverse transcriptase inhibitor [NNRTI], protease inhibitor [PI], and integrase strand transfer inhibito
Image
Published: 23 July 2024
Figure 3. Predicted intermediate to high drug resistance in Rhode Island, 2004–2021. A , Proportions of persons with predicted drug resistance per the colored legend (nucleoside reverse transcriptase inhibitor [NRTI], nonnucleoside reverse transcriptase inhibitor [NNRTI], protease inhibitor [PI], and integra
Journal Article
ACCEPTED MANUSCRIPT
Filemón Bucardo and others
The Journal of Infectious Diseases, jiae368, https://doi.org/10.1093/infdis/jiae368
Published: 23 July 2024
Image
Published: 23 July 2024
Figure 1. The antiretroviral therapy landscape in Rhode Island. The figure represents percentage of antiretroviral regimens annually from 1990 to 2021 based on the number of patient regimens per year, grouped based on the color legend, among a total clinic population of 2100. The most common specific regimen
Journal Article
Su Aung and others
The Journal of Infectious Diseases, jiae344, https://doi.org/10.1093/infdis/jiae344
Published: 23 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Filippo Mearelli and others
The Journal of Infectious Diseases, jiae370, https://doi.org/10.1093/infdis/jiae370
Published: 23 July 2024
Image
Published: 23 July 2024
Figure 4. One-, 2-, and 3-class drug resistance in Rhode Island, 2004–2021. A , Trends and annual prevalence of persons with acquired 1-, 2-, and 3-antiretroviral class resistance (colors according to legend). Annual resistance prevalence was calculated based on the number of individuals with specified resis
Journal Article
ACCEPTED MANUSCRIPT
Ruut Piri and others
The Journal of Infectious Diseases, jiae367, https://doi.org/10.1093/infdis/jiae367
Published: 23 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Nathaniel Bloom and others
The Journal of Infectious Diseases, jiae371, https://doi.org/10.1093/infdis/jiae371
Published: 22 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Kara W Chew and others
The Journal of Infectious Diseases, jiae369, https://doi.org/10.1093/infdis/jiae369
Published: 20 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Mitra Kashani and others
The Journal of Infectious Diseases, jiae363, https://doi.org/10.1093/infdis/jiae363
Published: 19 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Anuradha Rajamanickam and others
The Journal of Infectious Diseases, jiae365, https://doi.org/10.1093/infdis/jiae365
Published: 19 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Matthew E Levy and others
The Journal of Infectious Diseases, jiae364, https://doi.org/10.1093/infdis/jiae364
Published: 19 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Lindsay Hill-Batorski and others
The Journal of Infectious Diseases, jiae361, https://doi.org/10.1093/infdis/jiae361
Published: 16 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Christine Lacabaratz and others
The Journal of Infectious Diseases, jiae360, https://doi.org/10.1093/infdis/jiae360
Published: 16 July 2024
Journal Article
ACCEPTED MANUSCRIPT
Priyesh Agrawal and others
The Journal of Infectious Diseases, jiae362, https://doi.org/10.1093/infdis/jiae362
Published: 16 July 2024
Journal Article
ACCEPTED MANUSCRIPT
D El Safadi and others
The Journal of Infectious Diseases, jiae351, https://doi.org/10.1093/infdis/jiae351
Published: 16 July 2024